Sandimmune® (cyclosporine capsules, USP) 100 mg soft gelatin capsules and Neoral® (cyclosporine capsules, USP) MODIFIED 100 mg soft gelatin capsules prescription drug blister packages
Publicado el 18 de marzo de 2020
Resumen
CPSC registra el retiro 20091, publicado el 18 de marzo de 2020. Unidades reportadas: About 73,000.
Qué peligro representa
The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act (PPPA), posing a risk of poisoning if the contents are swallowed by young children.
Qué hacer
Consumers should immediately secure the product out of the sight and reach of children and contact the firm to request a free child-resistant pouch in which to store the blister package medications. Consumers can continue to use the medication as directed. The child-resistant pouches should be used to store these medications until new child-resistant blister packaging is available.
Recibe un correo cuando CPSC publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Distribuidor
- Novartis Pharmaceuticals Corporation, of East Hanover, N.J.
- País
- US
Retiros relacionados
- CPSCSoap Supply Co. Lye, Soap Makers Lye, California Soap Supply, Combo Pure Solutions, Red Crown High Test Lye,18 de marzo de 2020
- CPSCSodium Hydroxide, Lye/Caustic Soda and Potassium Hydroxide, Caustic Potash Ash18 de marzo de 2020
- CPSC100% Sodium Hydroxide Drain Cleaner18 de marzo de 2020
- CPSCHonda EB2200i, EU2200i, EU2200i Companion and EU2200i Camo Portable Generators17 de marzo de 2020
- CPSCFinch three-drawer dressers12 de marzo de 2020
- CPSCLine 6 Relay G10 Digital Wireless Guitar Systems and USB Charging Cables12 de marzo de 2020
Preguntas sobre este retiro
¿Sandimmune® (cyclosporine capsules, USP) 100 mg soft gelatin capsules and Neoral® (cyclosporine capsules, USP) MODIFIED 100 mg soft gelatin capsules prescription drug blister packages fue retirado del mercado?
Sí. CPSC publicó el retiro 20091 el 18 de marzo de 2020. Peligro reportado: The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act (PPPA), posing a risk of poisoning if the contents are swallowed by young children.
¿Qué debo hacer si tengo este producto?
Consumers should immediately secure the product out of the sight and reach of children and contact the firm to request a free child-resistant pouch in which to store the blister package medications. Consumers can continue to use the medication as directed. The child-resistant pouches should be used to store these medications until new child-resistant blister packaging is available.